Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy (Q44937306)

7 December 2017

Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy (English)

1 reference

7 December 2017

Robert E Schmidt

1

1 reference

7 December 2017

Denise A Dorsey

2

1 reference

7 December 2017

Lucie N Beaudet

3

1 reference

7 December 2017

Curtis A Parvin

4

1 reference

7 December 2017

Weixian Zhang

5

1 reference

7 December 2017

Anders A F Sima

6

1 reference

7 December 2017

1 May 2004

1 reference

Journal of Neuropathology & Experimental Neurology

7 December 2017

1 reference

7 December 2017

63

1 reference

7 December 2017

450-460

1 reference

7 December 2017

5

1 reference

Synaptic dysplasia in sympathetic autonomic ganglia

7 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Neuronal preservation in the sympathetic ganglia of rats with chronic streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

The genetic enhancement of memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

C-peptide and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Decrease in Serum Receptor-Reactive Somatomedin in Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Neurodegeneration is associated to changes in serum insulin-like growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: correlation with metabolic control and height attainment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Role of peptide growth factors in development of macrovascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Production of insulin-like growth factor I and its binding protein in rat hepatocytes cultured from diabetic and insulin-treated diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

The insulin-like growth factor system and neurological complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

Molecular basis for the insulinomimetic effects of C-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

C-peptide prevents hippocampal apoptosis in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNEN%2F63.5.450

21 January 2018

Identifiers

DOI

10.1093/JNEN/63.5.450

1 reference

7 December 2017

1 reference